The U.S. Meals and Drug Administration has authorized Andembry (garadacimab-gxii) as the one therapy focusing on issue XIIa for prophylactic…
Read More
The U.S. Meals and Drug Administration has authorized Andembry (garadacimab-gxii) as the one therapy focusing on issue XIIa for prophylactic…
Read More